1. Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First‐in‐Class Mirror‐Image Oligonucleotide Inhibitor of CXCL12. Issue 1 (19th March 2013) Authors: Vater, A; Sahlmann, J; Kröger, N; Zöllner, S; Lioznov, M; Maasch, C; Buchner, K; Vossmeyer, D; Schwoebel, F; Purschke, W G; Vonhoff, S; Kruschinski, A; Hübel, K; Humphrey, M; Klussmann, S; Fliegert, F Journal: Clinical pharmacology & therapeutics Issue: Volume 94:Issue 1(2013) Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects. (8th April 2016) Authors: Boyce, M; Warrington, S; Cortezi, B; Zöllner, S; Vauléon, S; Swinkels, D W; Summo, L; Schwoebel, F; Riecke, K Journal: British journal of pharmacology Issue: Volume 173:Number 10(2016:May) Page Start: 1580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗